Clinical Trials
12 trialsNCT00138216 2023-10-02
Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00919750 2018-07-16
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Children's Oncology Group
Completed
NCT01975116 2017-08-07
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00890435 2015-10-21
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Children's Oncology Group
Completed
NCT00003141 2014-03-28
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
Children's Oncology Group
Phase 1 Completed
NCT00002485 2014-02-14
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Children's Oncology Group
Completed
NCT00004078 2013-06-14
Irinotecan in Treating Children With Refractory Solid Tumors
Children's Oncology Group
Phase 2 Completed
NCT00503724 2012-03-06
Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00010114 2011-07-20
Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children
Pediatric Brain Tumor Consortium
Completed
NCT00098761 2011-06-30
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00015899 2009-10-14
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed
NCT00006246 2009-10-07
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
Pediatric Brain Tumor Consortium
Phase 1 Completed